Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation

Author: Edelman M.J.   Meyers F.J.   Miller T.R.   Williams S.G.   Gandour-Edwards R.   deVere White R.W.  

Publisher: Elsevier

ISSN: 0090-4295

Source: Urology, Vol.55, Iss.4, 2000-04, pp. : 521-525

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content